GH peak response to GHRH-arginine and cardiovascular risk factors, including obesity, insulin resistance, low levels of high density lipoprotein (HDL) cholesterol, elevated triglycerides, and hypertension. This evidence concerns the gene GHRH and obesity due to melanocortin 4 receptor deficiency.